Detalles de la búsqueda
1.
A higher score on the dermatology life quality index, being on systemic treatment and having a diagnosis of psoriatic arthritis is associated with increased costs in patients with plaque psoriasis.
Acta Derm Venereol
; 93(6): 684-8, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23603935
2.
Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries.
Rheumatology (Oxford)
; 51(2): 393-6, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22210658
3.
Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation.
Psychopharmacology (Berl)
; 161(2): 143-51, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-11981594
4.
Clinical and economic impact of etanercept in real-life: a prospective, non-interventional study of etanercept in the treatment of patients with moderate to severe plaque psoriasis in private dermatologist settings (ESTHER).
Eur J Dermatol
; 23(6): 774-81, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24334009
5.
The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy.
Acta Derm Venereol
; 88(5): 495-501, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18779890
6.
A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients.
Psychosomatics
; 44(3): 216-21, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12724503
Resultados
1 -
6
de 6
1
Próxima >
>>